137 related articles for article (PubMed ID: 36502355)
1. Lung cancer tumor markers in serous effusions and other body fluids.
Trapé J; Bérgamo S; González-Garcia L; González-Fernández C
Tumour Biol; 2024; 46(s1):S99-S110. PubMed ID: 36502355
[TBL] [Abstract][Full Text] [Related]
2. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
4. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
[TBL] [Abstract][Full Text] [Related]
5. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
6. Morphologic analysis of serous effusion cells by scanning electron microscopy.
Cappellari A; Furlan C; Cardellini P; Bagarella M; Corradi G
Tumori; 1992 Feb; 78(1):10-2. PubMed ID: 1609452
[TBL] [Abstract][Full Text] [Related]
7. Significance of pericellular lacunae in cell blocks of effusions.
Price BA; Ehya H; Lee JH
Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
[TBL] [Abstract][Full Text] [Related]
8. p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology.
Mayall F; Heryet A; Manga D; Kriegeskotten A
Cytopathology; 1997 Feb; 8(1):9-12. PubMed ID: 9068950
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of nodular histiocytic hyperplasia in serous effusions.
Naylor B
Diagn Cytopathol; 2002 Jan; 26(1):68. PubMed ID: 11782092
[No Abstract] [Full Text] [Related]
10. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.
Lew M; Cantley R; Heider A; Jing X
Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354
[TBL] [Abstract][Full Text] [Related]
12. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China.
Gong X; Shao S; Jin L; Fu Y; Wang L; Xiao X; Yang L; Zhao X
Diagn Cytopathol; 2020 Dec; 48(12):1173-1180. PubMed ID: 32757383
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in the diagnosis of malignant serous effusions.
Cascinu S; Del Ferro E; Barbanti I; Ligi M; Fedeli A; Catalano G
Am J Clin Oncol; 1997 Jun; 20(3):247-50. PubMed ID: 9167746
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of AgNOR technique in the interpretation of serous effusions].
Rocher AE; Blanco AM; Palaoro LA
Rev Med Chil; 2000 Sep; 128(9):963-8. PubMed ID: 11349500
[TBL] [Abstract][Full Text] [Related]
16. Ber-EP4 staining in effusion cytology: A potential source of false positives.
Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
[TBL] [Abstract][Full Text] [Related]
17. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
18. Pleural, peritoneal and pericardial effusions - a biochemical approach.
Kopcinovic LM; Culej J
Biochem Med (Zagreb); 2014; 24(1):123-37. PubMed ID: 24627721
[TBL] [Abstract][Full Text] [Related]
19. Malignant effusions: from diagnosis to biology.
Davidson B
Diagn Cytopathol; 2004 Oct; 31(4):246-54. PubMed ID: 15452897
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of clot examination for malignant cells in serous effusions.
Jalal R; Aftab K; Hasan SH; Pervez S
Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
